{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:16Z","timestamp":1787071036256,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Metastatic gallbladder cancer (GBC) is a highly fatal malignancy and it is difficult to treat the advanced stage of GBC. In India, northern and northeastern states are the worst affected by this disease. We, hereby, report the clinicoepidemiological and management profile of 242 patients of metastatic carcinoma of GB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this study, a total of 242 cases of metastatic GBC (detected either on the first presentation or during follow-up) were managed at the Department of Medical Oncology tertiary care oncology center in the northeast part of India from May 2018 to September 2019. On presentation, all patients were subjected to detailed history and clinical examination, followed by requisite investigations and were treated as per the existent guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>One-hundred and forty-two patients were female, while 100 patients were male out of 242 patients. Female patients with metastatic GBC presented with the mean age of 54, while for males, 51.4 years. The most common presentation was pain abdomen (81.8%), while the second most common was anorexia (77.2%), followed by weight loss (62.8%) and mass per abdomen (60.7%). The most common site of metastasis recorded in our study was the liver (79.7%), followed by nonregional abdominal lymph node (69.4%) and ascites (64.4%). Out of the 242 patients, 24 patients had presented in poor Eastern Cooperative Oncology Group Performance Status (\u22653) hence were deemed unfit for any oncological interventions. About 136 (56.1%) patients had presented with features of obstructive jaundice, however only 108 patients were subjected to biliary drainage procedure. After the biliary drainage procedures, only one-third (38 out of 136; 35.1%) of patients were finally able to receive chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In India, unfortunately, many patients present very late during the course of their illness. There is a need for the development of effective chemotherapy or targeted therapy and also there is an unmet need for patients' education. There has been an increase in the incidence of this malignancy, especially in the Northeast part of India; hence, it is the need of the hour to study various epidemiological and causative factors of the disease. Furthermore, the development of therapies for the effective management of this malignancy is really required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1213_20","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T07:32:56Z","timestamp":1629444776000},"page":"S428-S433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A clinicoepidemiological and management profile of metastatic carcinoma gallbladder in the northeast part of Indian patients in a tertiary care center"],"prefix":"10.4103","volume":"18","author":[{"given":"Anvesh","family":"Rathore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MS","family":"Shivshankara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Pandaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Arvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VP","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nikhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-45-20241021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0971-5851.158829","article-title":"Indian Council of Medical Research consensus document for the management of gall bladder cancer","volume":"36","author":"Shukla","year":"2015","journal-title":"Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology"},{"key":"R4-45-20241021","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","article-title":"Primary gallbladder cancer: Recognition of risk factors and the role of prophylactic cholecystectomy","volume":"95","author":"Sheth","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R5-45-20241021","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004230100220","article-title":"Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones","volume":"386","author":"Tazuma","year":"2001","journal-title":"Langenbecks Arch Surg"},{"key":"R6-45-20241021","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/0019-509X.197723","article-title":"Place of birth and risk of gallbladder cancer in India","volume":"53","author":"Mhatre","year":"2016","journal-title":"Indian J Cancer"},{"key":"R7-45-20241021","first-page":"99","article-title":"Gallbladder cancer: Epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R8-45-20241021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archsurg.2009.46","article-title":"Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: A single-institution experience","volume":"144","author":"Konstantinidis","year":"2009","journal-title":"Arch Surg"},{"key":"R9-45-20241021","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J Surg Oncol"},{"key":"R10-45-20241021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI114977","article-title":"Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism","volume":"87","author":"Everson","year":"1991","journal-title":"J Clin Invest"},{"key":"R11-45-20241021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/IJGC:35:1:061","article-title":"Do the progesterone receptors have a role to play in gallbladder cancer?","volume":"35","author":"Baskaran","year":"2005","journal-title":"Int J Gastrointest Cancer"},{"key":"R12-45-20241021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1477-7819-9-164","article-title":"Risk factors of gallbladder cancer in Karachi \u2013 A case-control study","volume":"9","author":"Alvi","year":"2011","journal-title":"World J Surg Oncol"},{"key":"R13-45-20241021","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008469-200508000-00011","article-title":"Patients with gallstones develop gallbladder cancer at an earlier age","volume":"14","author":"Dutta","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"R14-45-20241021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1440-1746.2005.03576.x","article-title":"Gallbladder cancer in India: A dismal picture","volume":"20","author":"Batra","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R15-45-20241021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jso.2930280109","article-title":"Primary carcinoma of the gall bladder: A review of a 16-year period at the University Hospital","volume":"28","author":"Shukla","year":"1985","journal-title":"J Surg Oncol"},{"key":"R16-45-20241021","first-page":"209","article-title":"Gallbladder cancer: An 'Indian' disease","volume":"16","author":"Kapoor","year":"2003","journal-title":"Natl Med J India"},{"key":"R17-45-20241021","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","article-title":"Gallbladder cancer: can newer insights improve the outcome?","volume":"27","author":"Dutta","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-45-20241021","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/apt.12655","article-title":"Systematic review with meta-analysis: The relationship between chronic Salmonella typhi carrier status and gall-bladder cancer","volume":"39","author":"Nagaraja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-45-20241021","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/89.15.1132","article-title":"Epidemiologic aspects of gallbladder cancer: A case-control study of the SEARCH Program of the International Agency for Research on Cancer","volume":"89","author":"Zatonski","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R20-45-20241021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0971-5851.51442","article-title":"Risk factors for gallbladder cancer : A population based case-control study in Delhi","volume":"29","author":"Tyagi","year":"2008","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R21-45-20241021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"key":"R22-45-20241021","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-008-9908-y","article-title":"Courvoisier's gallbladder: Law or sign?","volume":"33","author":"Fitzgerald","year":"2009","journal-title":"World J Surg"},{"key":"R23-45-20241021","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00330-002-1440-0","article-title":"The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder","volume":"12","author":"Kumaran","year":"2002","journal-title":"Eur Radiol"},{"key":"R24-45-20241021","first-page":"3375","article-title":"Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer","volume":"7","author":"Patt","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R25-45-20241021","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cncr.20368","article-title":"Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma","volume":"101","author":"Patt","year":"2004","journal-title":"Cancer"},{"key":"R26-45-20241021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:DRUG.0000011797.09549.53","article-title":"Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer","volume":"22","author":"Tsavaris","year":"2004","journal-title":"Invest New Drugs"},{"key":"R27-45-20241021","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bjc.6605211","article-title":"Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: A multicentre randomised phase II study \u2013 The UK ABC-01 study","volume":"101","author":"Valle","year":"2009","journal-title":"Br J Cancer"},{"key":"R28-45-20241021","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.COC.0000018037.59196.67","article-title":"Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder","volume":"26","author":"Malik","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"R29-45-20241021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/CRST.CRST_4_18","article-title":"Current management strategies in gallbladder cancers","volume":"1","author":"Ostwal","year":"2018","journal-title":"Cancer Res Stat Treat"},{"key":"R30-45-20241021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/JME.JME_78_20","article-title":"Clinical spectrum of carcinoma of the gallbladder in the Indian states of Uttarakhand and Western Uttar Pradesh: A retrospective study from a tertiary care hospital of Northern India","volume":"1","author":"Kumar","year":"2020","journal-title":"J Med Evid"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1213_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:36Z","timestamp":1787067636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1213_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1213_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}